Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Panhematin
Synonyms :
hemin
Class :
Blood components
Dosage Forms & Strengths Â
Powder for reconstitution Â
301mg/vial Â
7mg/mL  Â
Based on clinical signs, 1-4 mg/kg/day IV over 30 min 3-14 days; in even more severe instances, this dose may be repeated no sooner than every 12 hours.
Do Not exceed 6 mg/kg in a day.
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may reduce the therapeutic effect of hemin
may reduce the therapeutic effect of hemin
may reduce the therapeutic effect of hemin
may reduce the therapeutic effect of hemin
may reduce the therapeutic effect of hemin
hemin increases the effect of anticoagulants
hemin increases the effect of anticoagulants
the therapeutic effect of hemin may be reduced by the use of estrogen derivatives
the therapeutic effect of hemin may be reduced by the use of estrogen derivatives
bazedoxifene/conjugated estrogens
the therapeutic effect of hemin may be reduced by the use of estrogen derivatives
the therapeutic effect of hemin may be reduced by the use of estrogen derivatives
the therapeutic effect of hemin may be reduced by the use of estrogen derivatives
The therapeutic efficacy of hemin may be reduced by estrogen derivative
The therapeutic efficacy of hemin may be reduced by estrogen derivative
may increase the anti-coagulant action of anti-coagulants
estrogens esterified/methyltestosterone            Â
may decrease the therapeutic effect of estrogen derivatives
Adverse drug reactions Â
Frequency Not Defined Â
stomach pain Â
Phlebitis Â
irregular heartbeat Â
tiredness Â
Pyrexia Â
Bluish color Â
Pregnancy warnings:   
Pregnancy Category: CÂ
Lactation: Â
The drug excretion in breastmilk is unknown. Â
Pregnancy Categories:       Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were no enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category Â
 Â
Patient Information Leaflet   Â
Generic Name: heminÂ
Why do we use hemin? Â
hemin is a blood component used to treat Porphyria.Â